Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yeming Wang

Showing results (131-140 of 151) with videos related to

Pageof 16
Sort By:
Chest|March 2, 2024
Effect of Corticosteroids on Long-Term Humoral and Memory T-Cell Responses in Follow-Up Visit of Hospitalized Patients With COVID-19Yeming Wang, Li Guo, Guohui Fan, et al.
The Lancet Regional Health. Western Pacific|April 14, 2025
Health outcomes one year after Omicron infection among 12,789 adults: a community-based cross-sectional studyHui Zhang, Peng Yang, Xiaoying Gu, et al.
Chinese Medical Journal Pulmonary and Critical Care Medicine|August 22, 2024
Impact of corticosteroids on initiation and half-year durability of humoral response in COVID-19 survivorsYeming Wang, Li Guo, Guohui Fan, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 27, 2025
Efficacy and safety of single-dose suraxavir marboxil tablet in the treatment of acute uncomplicated influenza in adults: a multi-centre, randomized, double-blind, placebo-controlled phase 2 clinical trialYeming Wang, Hong Wang, Dong Liu, et al.
Nature Medicine|January 31, 2025
Author Correction: Single-dose suraxavir marboxil for acute uncomplicated influenza in adults and adolescents: a multicenter, randomized, double-blind, placebo-controlled phase 3 trialYeming Wang, Hong Wang, Yu Zhang, et al.
Science Bulletin|August 6, 2024
Longitudinal landscape of immune reconstitution after acute SARS-CoV-2 infection at single-cell resolutionLili Ren, Yiwei Liu, Yeming Wang, et al.
Nature Medicine|January 8, 2025
Single-dose suraxavir marboxil for acute uncomplicated influenza in adults and adolescents: a multicenter, randomized, double-blind, placebo-controlled phase 3 trialYeming Wang, Hong Wang, Yu Zhang, et al.
The Journal of Infectious Diseases|March 25, 2025
Efficacy and Safety of WXSH0208 Tablets in Treatment of Acute Uncomplicated Influenza Infection in Adults: A Multicenter Randomized, Double-Blind, Placebo-Controlled Phase 2 TrialWenhao Cao, Weihua Su, Xinyu Song, et al.
Lancet (London, England)|August 29, 2021
1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort studyLixue Huang, Qun Yao, Xiaoying Gu, et al.
Trials|May 26, 2020
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trialYeming Wang, Fei Zhou, Dingyu Zhang, et al.
Pageof 16

Showing results (131-140 of 151) with videos related to

Sort By:
Pageof 16
Chest|March 2, 2024
Effect of Corticosteroids on Long-Term Humoral and Memory T-Cell Responses in Follow-Up Visit of Hospitalized Patients With COVID-19Yeming Wang, Li Guo, Guohui Fan, et al.
The Lancet Regional Health. Western Pacific|April 14, 2025
Health outcomes one year after Omicron infection among 12,789 adults: a community-based cross-sectional studyHui Zhang, Peng Yang, Xiaoying Gu, et al.
Chinese Medical Journal Pulmonary and Critical Care Medicine|August 22, 2024
Impact of corticosteroids on initiation and half-year durability of humoral response in COVID-19 survivorsYeming Wang, Li Guo, Guohui Fan, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 27, 2025
Efficacy and safety of single-dose suraxavir marboxil tablet in the treatment of acute uncomplicated influenza in adults: a multi-centre, randomized, double-blind, placebo-controlled phase 2 clinical trialYeming Wang, Hong Wang, Dong Liu, et al.
Nature Medicine|January 31, 2025
Author Correction: Single-dose suraxavir marboxil for acute uncomplicated influenza in adults and adolescents: a multicenter, randomized, double-blind, placebo-controlled phase 3 trialYeming Wang, Hong Wang, Yu Zhang, et al.
Science Bulletin|August 6, 2024
Longitudinal landscape of immune reconstitution after acute SARS-CoV-2 infection at single-cell resolutionLili Ren, Yiwei Liu, Yeming Wang, et al.
Nature Medicine|January 8, 2025
Single-dose suraxavir marboxil for acute uncomplicated influenza in adults and adolescents: a multicenter, randomized, double-blind, placebo-controlled phase 3 trialYeming Wang, Hong Wang, Yu Zhang, et al.
The Journal of Infectious Diseases|March 25, 2025
Efficacy and Safety of WXSH0208 Tablets in Treatment of Acute Uncomplicated Influenza Infection in Adults: A Multicenter Randomized, Double-Blind, Placebo-Controlled Phase 2 TrialWenhao Cao, Weihua Su, Xinyu Song, et al.
Lancet (London, England)|August 29, 2021
1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort studyLixue Huang, Qun Yao, Xiaoying Gu, et al.
Trials|May 26, 2020
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trialYeming Wang, Fei Zhou, Dingyu Zhang, et al.
Pageof 16